Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Minority Interest (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Minority Interest for 4 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Minority Interest fell 38.89% year-over-year to $11.0 million, compared with a TTM value of $11.0 million through Dec 2025, down 38.89%, and an annual FY2025 reading of $11.0 million, down 38.89% over the prior year.
  • Minority Interest was $11.0 million for Q4 2025 at GE HealthCare Technologies, down from $23.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $230.0 million in Q4 2022 and bottomed at $11.0 million in Q4 2025.
  • Average Minority Interest over 4 years is $144.1 million, with a median of $187.5 million recorded in 2022.
  • The sharpest move saw Minority Interest crashed 93.03% in 2024, then skyrocketed 1407.14% in 2025.
  • Year by year, Minority Interest stood at $230.0 million in 2022, then dropped by 28.26% to $165.0 million in 2023, then crashed by 89.09% to $18.0 million in 2024, then tumbled by 38.89% to $11.0 million in 2025.
  • Business Quant data shows Minority Interest for GEHC at $11.0 million in Q4 2025, $23.0 million in Q3 2025, and $220.0 million in Q2 2025.